Bausch + Lomb Corporation (BLCO)
NYSE · Healthcare
Bausch + Lomb Corporation EBITDA 2020–2025
Bausch + Lomb Corporation annual/quarterly ebitda history and growth rate from 2020 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Bausch + Lomb Corporation ebitda for the quarter ending March 31, 2026 was 134.0 M, a 482.61% increase year-over-year.
- Bausch + Lomb Corporation ebitda for the twelve months ending March 31, 2026 was 362.0 M.
- Bausch + Lomb Corporation annual ebitda for 2025 was 534.0 M, a 10.70% decrease from 2024.
- Bausch + Lomb Corporation annual ebitda for 2024 was 598.0 M, a 16.80% increase from 2023.
- Bausch + Lomb Corporation annual ebitda for 2023 was 512.0 M, a 12.63% decrease from 2022.
- Bausch + Lomb Corporation annual ebitda for 2022 was 586.0 M.
EBITDA
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Bausch + Lomb Corporation EBITDA — FAQ
Bausch + Lomb Corporation (BLCO) ebitda over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BLCO's ebitda history?
The chart and table above show Bausch + Lomb Corporation's ebitda by year and by quarter, including the growth rate.